Cita APA (7a ed.)
Roy, S., Whitehead, T. D., Li, S., Ademuyiwa, F. O., Wahl, R. L., Dehdashti, F., & Shoghi, K. I. (2022). Co-clinical FDG-PET radiomic signature in predicting response to neoadjuvant chemotherapy in triple-negative breast cancer. European Journal of Nuclear Medicine & Molecular Imaging, 49(2), 550-563.
Cita Chicago Style (17a ed.)
Roy, Sudipta, Timothy D. Whitehead, Shunqiang Li, Foluso O. Ademuyiwa, Richard L. Wahl, Farrokh Dehdashti, y Kooresh I. Shoghi. "Co-clinical FDG-PET Radiomic Signature in Predicting Response to Neoadjuvant Chemotherapy in Triple-negative Breast Cancer." European Journal of Nuclear Medicine & Molecular Imaging 49, no. 2 (2022): 550-563.
Cita MLA (9a ed.)
Roy, Sudipta, et al. "Co-clinical FDG-PET Radiomic Signature in Predicting Response to Neoadjuvant Chemotherapy in Triple-negative Breast Cancer." European Journal of Nuclear Medicine & Molecular Imaging, vol. 49, no. 2, 2022, pp. 550-563.
Precaución: Estas citas no son 100% exactas.